Breast Cancer, Panic Disorder, and CYP2D6: A Case Study

被引：0
|
作者：
Rettig, Amy [1 ]
机构：
[1] Ohio State Univ, Arthur G James Canc Hosp, Comprehens Canc Ctr, Columbus, OH 43210 USA
来源：
CLINICAL JOURNAL OF ONCOLOGY NURSING | 2012年 / 16卷 / 03期
关键词：
TAMOXIFEN;
D O I：
10.1188/12.CJON.314-315
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
When patients with breast cancer also present with mental health issues, the psychiatric mental health advanced practice RN is an appropriate provider for treatment and medication management. Collaboration with the oncology advanced practice nurse and the rest of the healthcare team can provide personalized, comprehensive care to this patient population. This article describes one example.
引用
收藏
页码：314 / +
页数：3
相关论文
共 50 条
  • [21] CYP2D6 Gene Variants and Their Association with Breast Cancer Susceptibility
    Abraham, Jean E.
    Maranian, Mel J.
    Driver, Kristy E.
    Platte, Radka
    Kalmyrzaev, Bolot
    Baynes, Caroline
    Luccarini, Craig
    Earl, Helena M.
    Dunning, Alison M.
    Pharoah, Paul D. P.
    Caldas, Carlos
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (06) : 1255 - 1258
  • [22] IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM
    Nahid, N.
    Kanumuri, S.
    Sharma, A.
    Wang, D.
    Johnson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S74 - S75
  • [23] CYP2D6 Inhibition and Breast Cancer Recurrence in a Population-Based Study in Denmark
    Lash, Timothy L.
    Cronin-Fenton, Deirdre
    Ahern, Thomas P.
    Rosenberg, Carol L.
    Lunetta, Kathryn L.
    Silliman, Rebecca A.
    Garne, Jens Peter
    Sorensen, Henrik Toft
    Hellberg, Ylva
    Christensen, Mariann
    Pedersen, Lars
    Hamilton-Dutoit, Stephen
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (06): : 489 - 500
  • [24] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [25] Association Between CYP2D6 Polymorphisms and Breast Cancer Outcomes Reply
    Schroth, Werner
    Schwab, Matthias
    Brauch, Hiltrud
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (06): : 517 - 517
  • [26] Role of CYP2D6 testing in selection of endocrine therapy for breast cancer
    Stebbing, Justin
    Stearns, Vared
    Davidson, Nancy E.
    PHARMACOGENOMICS, 2007, 8 (01) : 1 - 3
  • [27] Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation:: a study of mutations CYP2D6*3 and CYP2D6*4
    Monek, O
    Paintaud, G
    Bechtel, Y
    Miguet, JP
    Mantion, G
    Bechtel, PR
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (01) : 47 - 52
  • [28] Impact of CYP2D6 inhibitors on tamoxifen metabolism in breast cancer patients
    Keller, Denise
    Medwid, Samantha
    Schwarz, Ute
    Legan, Robin
    Kim, Richard
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 250 - 253
  • [29] Re: CYP2D6 Genotyping and the Use of Tamoxifen in Breast Cancer Response
    Berry, Donald A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (02):
  • [30] CYP2D6*4 allele and breast cancer risk: Is there any association?
    Fernandez-Santander, Ana
    del Saz Sanchez, Miguel
    Tejerina Gomez, Armando
    Bandres Moya, Fernando
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (02): : 157 - 159
12345